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Edited by Jesus AvilaAbstract We have previously shown that the pro-peptide of
human nerve growth factor (NGF) facilitates oxidative folding
of the mature part. For the analysis of functional speciﬁcities
of the pro-peptides of NGF and the related neurotrophin-3
(NT-3) with respect to structure formation, chimeric proteins
with swapped pro-peptides were generated. Neither the structure
nor the stability of the mature domains was inﬂuenced by the het-
erologous pro-peptides. For the pro-peptide of NT-3 fused to the
mature part of NGF, stabilization of the pro-peptide moiety by
the NGF part was observed. Folding kinetics and renaturation
yields of this chimeric protein were comparable to those of
proNGF. Our results demonstrate functional interchangeability
between the pro-peptides of NGF and NT-3 with respect to their
role in assisting oxidative folding of the mature part.
 2007 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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Nerve growth factor was described as a neuronal growth fac-
tor more than 50 years ago [1,2]. Its central role in the mainte-
nance of neuronal and certain non-neuronal tissue types is
reﬂected by an ever-increasing output of publications dealing
with this growth factor. Besides NGF also the related neuro-
trophins, NT-3, NT-4/5, NT-6, NT-7 and brain derived neuro-
trophic factor (BDNF) exert similar biological activities. The
neurotrophins share a sequence homology of more than
50%. Their biological activities are mediated by binding to
receptor complexes consisting of the neurotrophin receptor
p75NTR and the neurotrophin speciﬁc receptors TrkA
(NGF), TrkB (BDNF) and TrkC (NT-3) (for reviews see
[3,4]). The primary sequence homology is reﬂected at the level
of secondary, tertiary and quaternary structure: the proteins
are characterized by predominating b-sheet structures, they*Corresponding author. Fax: + 49 345 55 27 013.
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doi:10.1016/j.febslet.2007.07.063display elongated shapes and assemble into homodimers with
the two protomers in parallel association [5]. With the excep-
tion of NT-6, which contains only two disulﬁde bridges [6],
neurotrophin protomers contain three disulﬁde bonds that
associate to a cystine knot. This motif describes a disulﬁde
bond pattern in which two disulﬁdes connect the polypeptide
backbone to a ring through which a third disulﬁde bond
threads [5,7]. Besides these shared structural features, close
similarities of the neurotrophins also exist at the level of the
primary translation product. All members of the family are
synthesized as pre-pro-proteins. The pre-sequence targets the
proteins to the secretory endoplasmic reticulum. The biological
roles of the pro-peptides have recently received intense scien-
tiﬁc attention, as numerous lines of evidence indicate that
the pro-peptides possess biological functions beyond their
roles in the biogenesis of the mature parts (for review see
[8]). These studies are complemented by eﬀorts to elucidate
the structure(s) of the pro-peptide moiety [9].
The pro-peptide of NGF has been reported to promote
secretion of proNGF [10]. In vitro, the pro-peptide guides oxi-
dative folding of the mature part [11,12]. Very likely, this fold-
ing promoting function also exists in vivo. More recently, a
pro-apoptotic function has been reported which is elicited by
binding of proNGF to a complex consisting of p75NTR and
a pro-form speciﬁc receptor, sortilin [13,14]. Similarly, pro-
BDNF has been described to elicit apoptosis by binding to
this receptor complex [15]. Pro-form-induced apoptosis, how-
ever, may be restricted to certain tissue or cell types as also
growth promoting functions of proNGF have been observed
[16,17].
Neurotrophins share high sequence homologies in their
mature parts, e.g. human NGF and NT-3 display 57% amino
acid identity. Homology is considerably lower in the pro-pep-
tide moieties: Upon the introduction of a 17 amino acid gap in
the pro-peptide of NGF in order to obtain a maximal align-
ment, only 25% identity can be observed. In the present work
we wanted to address the question, whether, in spite of their
low homology, the pro-peptides of the two neurotrophins
NGF and NT-3 could be swapped and still retain their func-
tion in assisting structure formation of the mature parts. The
results presented here demonstrate that the pro-peptide of
NT-3, when fused to the mature part of NGF (proNT-3/mat-
NGF), promotes oxidative folding of NGF in a manner similar
as the homologous pro-peptide. Furthermore, with the fusion
of the pro-peptide of NGF linked to the mature part of NT-3
(proNGF/matNT-3) indirect evidence was obtained, that also
here the heterologous pro-peptide stimulated structure forma-
tion of the mature part.blished by Elsevier B.V. All rights reserved.
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2.1. Cloning and recombinant protein production
The expression construct for proNGF has been described [11]. Like-
wise, the DNA encoding human proNT-3 (source: EST clone, Gen-
Bank accession number: AA448311) was ampliﬁed using the forward
primer 5 0GTG CGA CCC ATA TGA ACA ACA TGG ATC AAA
GG and the reverse primer 5 0 GCG GGA TCC TCA TGT TCT
TCC GAT TTT TC. The ampliﬁcation product was cloned into
pET11a via NdeI and BamHI restrictions (Novagen, Bad Soden, Ger-
many). For a related study, mutations had been introduced into the
furin cleavage site of proNGF and proNT-3 to render the pro-forms
more resistant towards proteolysis [18,19]. In detail, codons for
Lys120 and Arg121 in proNGF, and Arg136 and Arg138 in proNT-3,
were replaced by codons for alanine by site-directed mutagenesis
according to the QuikChange Site-Directed Mutagenesis Kit (Strata-
gene, La Jolla, CA, USA). This DNA was subsequently used as tem-
plate DNA for construction of the chimeric proteins. Constructs for
the chimera with heterologous pro-peptides were obtained by fusion
PCR: Fusion primers (MWG Biotech AG, Ebersberg, Germany) were
designed corresponding to the C-terminal parts of the pro-domains
and the N-terminal parts of the heterologous mature domains. The
sequences were 5 0ACT CAC AGG AGC GCC GCC TAC GCG
GAG CAT AAG AGT for proNGF/matNT-3 and 5 0ACA TCA
CGG GCC AAA GCC TCA TCA TCC CAT CCC ATC for
proNT-3/matNGF. DNA coding for the pro-domains was ampliﬁed
with forward primers corresponding to the N-termini of the respective
pro-proteins (proNT-3-forward, see above, primers for proNGF see
[11]) and the corresponding reverse fusion primers. Likewise, frag-
ments coding for the mature parts were ampliﬁed using the fusion
primers and reversed primers corresponding to the C-termini of
NGF and NT-3. After puriﬁcation of the PCR products, the chimeric
full-length fusion constructs were obtained by another ampliﬁcation
round with the self-priming fragments and the outside primers. The fu-
sion fragments were cloned into pET11a via NdeI and BamHI sites.
The correct sequences were conﬁrmed by sequencing. Recombinant
gene expression and all subsequent steps were performed as described
previously [11].2.2. Fluorescence and circular dichroism (CD-) spectroscopy
Fluorescence measurements were carried out at a FluoroMax-2
(Jobin-Yvon-Spex, SPEX Instruments, Edison, NJ, USA). Slit widths
for both excitation and emission wavelengths were 5 nm. Experiments
were performed in 50 mM Na–phosphate buﬀer, pH 7.0, and 1 mM
EDTA at 20 C in 1 cm cuvettes. For monitoring unfolding and fold-
ing transitions, the excitation wavelength was 280 nm, and emission
was recorded at 325 nm. Far UV-CD spectra were recorded at a Jasco
J710 spectropolarimeter. Spectra of native and unfolded protein were
recorded between 190 and 260 nm in 50 mM Na–phosphate, pH 7.0
at 20 C in 0.5 mm cuvettes. Proteins were denatured by an over night
incubation in 6 M guanidinium hydrochloride (GdmCl), 50 mM Na–
phosphate, pH 7.0. Spectra were buﬀer-corrected, and mean residue
ellipticities were calculated according to [20].2.3. Quantiﬁcation of renaturation kinetics
Folding kinetics were analyzed by RP-HPLC as described previously
[12]. Folded proteins were denatured by an over night dialysis against
100 mMTris/HCl, 6 MGdmCl, 10 mMEDTA, pH 8.5. Protein concen-
tration was 4.35 mg/ml for proNGF and 3.10 mg/ml for proNT-3/mat-
NGF. Solid dithiothreitol (DTT) was added to a ﬁnal concentration of
100 mMto reduce disulﬁde bonds. After 2 h incubation at room temper-
ature, DTT was removed by excessive dialysis against 6 MGdmCl. The
pHwas adjusted to pH 4.0 to prevent re-oxidation bymolecular oxygen.
Reduced, denatured protein was diluted into refolding buﬀer to a ﬁnal
concentration of 50 lg/ml. The residual GdmCl concentration was
68 mM in case of proNGF and 96 mM in case of proNT-3/matNGF.
At the indicated time points, aliquots of 463 ll were removed, and disul-
ﬁde bond re-shuﬄing was stopped by the addition of 37 ll 32% HCl.
Subsequently, samples were loaded on a VYDAC 214MS 54, C4,
5 mm, 4.6 · 250 mm (GRACE VYDAC, Hesperia, CA, USA) equili-
brated with 6% solvent B [solvent A: 0.1% (v/v) triﬂuoroacetic acid in
water; solvent B: 0.07% (v/v) triﬂuoroacetic acid in 80% (v/v) aqueous
acetonitrile]. Analytic separation was performed on a Gynkothek
HPLC system (Dionex SoftronGmbH,Germering,Germany). The pro-tein was eluted at 20 Cat a ﬂow rate of 0.8 ml min1 in a non-linear gra-
dient (0–4 min: 6% solvent B; 4–9 min: 6–30% B; 9–24 min: 30–69% B,
24–25 min: 69–100% B; 25–30 min: 100% B). For quantiﬁcation of re-
folded species, peak areas were determined. Calibration was performed
with puriﬁed refolded proNGF.3. Results and discussion
3.1. The mature parts of NGF and NT-3 dominate structural
properties of the pro-forms
ProNGF, proNT-3, and the chimeric proteins proNT-3/mat-
NGF and proNGF/matNT-3 were recombinantly expressed as
inclusion bodies. Isolation of inclusion bodies and the follow-
ing steps yielding native protein were performed as described
previously [11]. After two days renaturation, similar yields of
all four renatured proteins were observed. Since refolding of
mature NT-3 has been reported to require several weeks [21],
we concluded that also in case of proNT-3, the pro-peptide
facilitates oxidative structure formation of the mature part as
previously observed for proNGF [11,12].
For the assessment of an inﬂuence of the heterologous pro-
peptides on the secondary structures, far-UV CD spectroscopy
was performed. CD spectra of proNGF and proNT-3 resem-
bled those of the mature growth factors [11,22]. In the chimeric
proteins, the spectrum of proNGF/matNT-3 is almost super-
imposable with that of proNT-3, while the spectrum of
proNT-3/matNGF is very similar to that of proNGF
(Fig. 1A–D). Thus, the secondary structure in the chimera is
dominated by the mature parts, in agreement with what has
been observed for proNGF [11].3.2. The chimera exhibit biphasic unfolding transitions as
proNGF and proNT-3
Denaturant-induced unfolding of proNGF under non-
reducing conditions has been shown to involve two transitions
of which the ﬁrst transition, at low GdmCl concentrations,
reﬂects unfolding of the pro-peptide moiety and the second,
at higher GdmCl concentrations, that of the mature part
[23]. In order to investigate whether unfolding of the pro-pep-
tide and mature parts could also be monitored as separate
transitions in proNT-3 and the chimeric proteins, ﬂuorescence
emission was recorded at 2.5 and 6.0 M GdmCl, concentra-
tions that unfold the pro-peptide and mature part of proNGF,
respectively [23]. As with proNGF, two emission maxima were
recorded at the two GdmCl concentrations likely reﬂecting
unfolding of the pro-peptide moieties and the mature parts
of proNT-3 and the chimeric proteins (Fig. 2A–D). The red
shifts of the ﬂuorescence maxima indicate that tryptophan res-
idues are exposed during unfolding. ProNGF contains a single
tryptophan in the pro-peptide moiety and three tryptophans in
the mature part. The pro-peptide of NT-3 lacks tryptophans,
while the mature part contains four tryptophans. Therefore,
the red shift observed upon unfolding of the pro-peptide
moiety of proNT-3/matNGF by 2.5 M GdmCl (Fig. 2B) must
result from solvent exposure of a tryptophan residue in the ma-
ture part due to a denaturant-induced dissociation of the pro-
peptide from the mature part. Several lines of evidence indicate
that the ﬂuorescence red shifts observed under these conditions
reﬂect exposure of Trp21 in mature NGF: (1) Earlier investiga-
tions revealed a more exposed location of Trp21 compared to
the other two tryptophan residues which are more buried
Fig. 1. Comparison of chimeric and natural pro-forms by CD spectroscopy. Far-UV CD-spectra of proNGF (A), proNT-3/matNGF (B), proNT-3
(C) and proNGF/matNT-3 (D) were recorded at 20 C in 50 mM Na–phosphate buﬀer, pH 7.0 in 0.5 mm cuvettes. Spectra were recorded in the
absence (solid line) and in the presence (dotted) of 6 M GdmCl. Protein concentrations were: proNGF: 0.58 mg/ml; proNT-3: 0.25 mg/ml; proNT-3/
matNGF: 0.34 mg/ml; proNGF/matNT-3: 0.2 mg/ml.
Fig. 2. Fluorescence spectra of native and denatured pro-forms. Fluorescence emission spectra of proNGF (A), proNT-3/matNGF (B), proNT-3 (C)
and proNGF/matNT-3 (D) in the absence (—) and presence of 2.5 M (  ) and 6 M GdmCl (- - -). Spectra were recorded at 20 C in 50 mM Na–
phosphate buﬀer, 0.5 M (NH4)2SO4, 1 mM EDTA, pH 7.0. Protein concentration was 10 lg/ml for all proteins. Excitation wavelength was at
280 nm. Spectra represent the average of three measurements and are buﬀer-corrected.
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of mature NGF in binding to TrkA has been suggested [26].
The alignment of NGF and NT-3 reveals the conserved posi-
tion of a tryptophan residue in NT-3 [6]. Thus, also for the
pro-peptide unfolding of proNT-3, the red shift probably indi-
cates the dissociation of the pro-peptide moiety from the ma-
ture part (Fig. 2C). In a previous publication we
hypothesized that the lower aﬃnity of proNGF towards TrkA
in comparison to NGF may be due to partial overlap of recep-
tor and pro-peptide interaction sites close to Trp21 in the ma-
ture part [27].Fig. 3. GdmCl-induced denaturation of natural and chimeric pro-forms. pro
(D) were diluted to ﬁnal concentrations of 10 lg/ml in 50 mM Na–phosphate
indicated GdmCl concentrations and incubated over night at 20 C. Emission
was detected at 20 C. Fluorescence signals were normalized.
Fig. 4. Refolding kinetics of proNGF (A) and proNT-3/matNGF (B). Re
concentrations of 50 lg/ml. At the indicated time points aliquots were r
Subsequently, refolded species were separated by RP-HPLC. For quantiﬁcat
native reference protein.For an exact determination of the unfolding transitions, the
proteins were stabilized in 0.5 M (NH4)2SO4 as previous stud-
ies demonstrated that the pro-peptide of NGF is only margin-
ally stable at room temperature in the absence of (NH4)2SO4
[23]. Denaturant-induced unfolding of proNT-3 and the chi-
meric proteins was reversible (data not shown) as previously
observed for proNGF [23]. As with proNGF, two transitions
were observed in all cases, likely reﬂecting unfolding of the
pro-peptide and the mature part [11,23]. Folding transitions
of the mature parts were in a comparable GdmCl range, inde-
pendent of whether the mature parts had their cognate or theNGF (A), proNT-3/matNGF (B), proNT-3 (C) and proNGF/matNT-3
buﬀer, 0.5 M (NH4)2SO4, 1 mM EDTA, pH 7.0, in the presence of the
spectra at 325 nm were measured upon excitation at 280 nm. Emission
duced, denatured proteins were diluted into refolding buﬀer to ﬁnal
emoved and refolding was stopped by addition of 37 ll 32% HCl.
ion of the native species, peak areas were determined and compared to
A. Hauburger et al. / FEBS Letters 581 (2007) 4159–4164 4163heterologous pro-peptide bound. GdmCl-induced unfolding
transitions of mature NT-3 have been reported previously to
occur at a transition midpoint of ca. 3.4 M [28]. The same tran-
sition midpoint was determined by our unfolding experiments
for the mature part of proNT-3. Strikingly, unfolding of the
NGF pro-peptide linked to NT-3 is considerably less coopera-
tive (Fig. 3D) than in proNGF (Fig. 3A) pointing to a reduced
stabilization of the pro-peptide moiety by the mature part of
NT-3. Likewise, the transition midpoint of the pro-peptide
of NT-3 linked to NGF was shifted to ca. 1.8 M GdmCl
(Fig. 3B) compared to the transition midpoint at ca. 1.0 M
in proNT-3 (Fig. 3C). These observations imply that associa-
tion with the mature parts generally inﬂuences the stabilities
of the pro-peptide moieties and conﬁrm our previous studies
that revealed stabilization of the pro-peptide moiety of NGF
by the mature part [23,27].3.3. The pro-peptide of NT-3 facilitates oxidative folding of
NGF
Next, we asked how the heterologous pro-peptides inﬂuence
the oxidative folding of the mature parts. To address this
question, folded proNT-3/matNGF and as a reference,
proNGF were reduced and denatured. Refolding was initiated
by dilution into refolding buﬀer [11]. For quantiﬁcation of re-
folded species, aliquots were removed and protein species were
separated by RP-HPLC [12]. Refolding yields of proNGF and
the chimeric protein were comparable (Fig. 4A, B). The kinet-
ics of formation of native species were similar as well, apart
from a small lag phase of 25 min in case of proNT-3/mat-
NGF. Unfortunately, the corresponding experiment with
proNGF/matNT-3 and proNT-3 could not be performed in
quantitative terms, as denatured and refolded species could
neither be separated by RP-HPLC nor size exclusion chroma-
tography (data not shown). However, renaturation of
proNGF/matNT-3 and proNT-3 from inclusion body material
was allowed to proceed under our standard conditions for
24 h (see above). After this renaturation period, with all four
proteins comparable yields were obtained. We therefore
assume that also in case of proNT-3 and the proNGF-
matNT-3 chimera, the pro-peptide can facilitate oxidative
folding of the mature part.
In summary, these results demonstrate for the proNT-3/mat-
NGF chimera and indicate in case of the proNGF/matNT-3
that the pro-peptides of NGF and NT-3 can be exchanged
without signiﬁcant changes in renaturation kinetics and yields
of the pro-proteins. Our ﬁndings show that the pro-peptides of
the two neurotrophins are interchangeable in their role as
intramolecular promoters of oxidative structure formation.
Though possessing only limited homologies, the pro-peptides
of NGF and NT-3 may associate in a similar way with the ma-
ture parts by adopting similar three-dimensional structures.
The formation of comparable three-dimensional structures
during oxidative folding could furthermore explain that the
pro-peptides can be exchanged without aﬀecting their folding
assisting roles. Corresponding low speciﬁcities of the pro-pep-
tides may be anticipated for BDNF and other members of the
neurotrophin family.Acknowledgements:We thank Brigitte So¨hling, Hauke Lilie and Chris-
tian Lange for critical comments. This work was supported by the
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